Nicotinamide Riboside as an Enhancer of Exercise Therapy in Hypertensive Older Adults

Sponsor: University of Florida
Collaborator: National Institute on Aging (NIA)

Purpose

More that 80% of older adults have hypertension, with higher prevalence of high systolic blood pressure (SBP) putting them at high risk for cardiovascular (CV) disease and death. Novel compound, nicotinamide riboside may enhance the effects of exercise therapy in hypertensive older adults.

Study Design

Randomized, double blind, placebo controlled, parallel assignment

Dose

1000mg/day

Length of Intervention

6 weeks

Intrinsic Capacity

Vitality

Status

Not yet recruiting

Condition or Disease 

Hypertension

Timeline estimations sourced on clinicaltrials.gov. All timing subject to change.

Clinical Studies, Vitality, Not Yet RecruitingANAD Staff